ReviewExperimental and therapeutic medicine2021

Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review).

Mariana Cornelia Tilinca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.